With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Improving Development of and Patient Access to Early Phase Pediatric Cancer Clinical Trials||Seattle Children's Hospital and Regional Medical Center / Russ Geyer||Phase I/II Infrastructure Grants||2010||Washington|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors||Fred Hutchinson Cancer Research Center / Beth Mueller, PhD||Epidemiology Grants||2014||Washington|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen||RUNX1 Early Career Investigator Grants||2022||Washington|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|
|Aberrant DNA methylation in Ewing sarcoma.||Fred Hutchinson Cancer Research Center / Scott Borinstein||Young Investigator Grants||2009||Washington|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|Targeting EZHIP as a therapeutic strategy for infantile ependymomas||University of Wisconsin - Madison / Peter Lewis, PhD||Innovation Grants||2021||Wisconsin|
|Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb||University of Wisconsin - Madison / Paul Sondel, MD, PhD||Innovation Grants||2015||Wisconsin|
|Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy||University of Wisconsin - Madison / Paul Sondel, MD, PhD||Innovation Grants||2022||Wisconsin|